$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
The latest progress and research results of domestic clinical trials of vorasidenib-VORANIGO
2026-02-01 22:25:32
Check Details
Correct usage, dosage and dosage adjustment standards of eflornithine (IWILFIN)
2026-02-01 22:25:32
Check Details
The latest domestic approval time and application prospects of odevixibat
2026-02-01 22:25:32
Check Details
Comparison of the mechanism of action and clinical effects of donepezil (Aricept) and rivastigmine
2026-02-01 22:25:32
Check Details
Comprehensive analysis of the drug properties, specifications and packaging information of Fidaxomicin
2026-02-01 22:25:32
Check Details
How to safely use ponatinib and dosage adjustment recommendations in patients with hepatic insufficiency
2026-02-01 22:25:32
Check Details
Whether Trelagliptin can cure diabetes and the actual effect of long-term treatment
2026-02-01 22:25:32
Check Details
Possible side effects of Inalisate (Iheli) and scientific countermeasures
2026-02-01 22:25:32
Check Details
Analysis of how long it takes for Abatacept injection to take effect and how long it lasts
2026-02-01 22:25:32
Check Details
What is the approximate price of a box of acotinib/acabrutinib on the market?
2026-02-01 22:25:32
Check Details
New 10-year data shows ibrutinib/Eco has durable efficacy in CLL/SLL
2026-02-01 22:25:32
Check Details
INCB057643 combined with ruxolitinib tablets/ruxolitinib can improve symptoms in patients with myelofibrosis
2026-02-01 22:25:32
Check Details
1
2
...
1988
1989
1990
1991
1992
1993
1994
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma